Mono-symptomatic Fabry disease in a population with mild-to-moderate left ventricular hypertrophy

Fabry disease (FD) results from a deficiency in the exoglycohydrolase, α-galactosidase A (AGA), an enzyme required for the sequential degradation of glycosphingolipids, which consequently accumulate in the lysosomes of affected cells. An X-linked inherited metabolic disorder, FD has a high incidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuller, Maria, Perry, Rebecca, Saiedi, Madiha, Fletcher, Janice M., Selvanayagam, Joseph B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733018/
https://www.ncbi.nlm.nih.gov/pubmed/33335842
http://dx.doi.org/10.1016/j.ymgmr.2020.100697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733018/
https://www.ncbi.nlm.nih.gov/pubmed/33335842
http://dx.doi.org/10.1016/j.ymgmr.2020.100697

Ejemplares similares